This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cost-effectiveness in the novel approach in vaccinated and unvaccinated women less than 30 years old
Timeframe: Up to 4 years
Cost-effectiveness in the standard approach in vaccinated and unvaccinated women less than 30 years old
Timeframe: Up to 4 years
Overall cost-effectiveness and acceptability
Timeframe: Up to 4 years
Sensitivity and specificity for CIN 1+ of currently recommended in-clinic cytology screening
Timeframe: Up to 4 years
Sensitivity and specificity for CIN 1+ of novel home-based testing
Timeframe: Up to 4 years
Sensitivity and specificity of the novel approach in vaccinated women less than 30 years old
Timeframe: Up to 4 years
Sensitivity and specificity of the standard approach in vaccinated women less than 30 years old
Timeframe: Up to 4 years